scholarly journals Discovery of Herbacetin as a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy (Adv. Sci. 2/2022)

2022 ◽  
Vol 9 (2) ◽  
pp. 2270009
Author(s):  
Shujing Zhang ◽  
Yingchao Wang ◽  
Min Yu ◽  
Ye Shang ◽  
Yanxu Chang ◽  
...  
Therapy ◽  
2005 ◽  
Vol 2 (3) ◽  
pp. 415-423
Author(s):  
Antony Halapas ◽  
Peter Lembessis ◽  
Antigone Sourla ◽  
Costas Pantos ◽  
Dennis V Cokkinos ◽  
...  

10.2741/2681 ◽  
2008 ◽  
Vol 13 (13) ◽  
pp. 312 ◽  
Author(s):  
Daniele Catalucci

2019 ◽  
Vol 12 (12) ◽  
pp. e225879 ◽  
Author(s):  
Warner Mbuila Mampuya ◽  
Jonathan Dumont ◽  
Francois Lamontagne

In the perioperative setting, norepinephrine is used to increase blood pressure, an effect mediated mostly via arterial and venous vasoconstriction. Thus, norepinephrine is, allegedly, less likely to cause or worsen left ventricular outflow tract obstruction (LVOTO) than other inotropes. We report a case of norepinephrine-associated dynamic LVOTO and systolic anterior movement in a predisposed patient. This report highlights that unrecognised dynamic LVOTO may worsen shock parameters in patients treated with norepinephrine who have underlying myocardial hypertrophy.


2021 ◽  
Vol 77 (23) ◽  
pp. 2923-2935
Author(s):  
Rabea Hinkel ◽  
Sandor Batkai ◽  
Andrea Bähr ◽  
Tarik Bozoglu ◽  
Sarah Straub ◽  
...  

2010 ◽  
Vol 48 (1) ◽  
pp. 211-219 ◽  
Author(s):  
Dazhi Xiong ◽  
Nathanael S. Heyman ◽  
Judith Airey ◽  
Mi Zhang ◽  
Cherie A. Singer ◽  
...  

2021 ◽  
Vol 271 ◽  
pp. 113833
Author(s):  
Xiang-Yang Chen ◽  
Xiao-He Chen ◽  
Lin Li ◽  
Cong-Ping Su ◽  
Yan-Ling Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document